awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37670065-E062D082-50FD-4A34-A1D2-2D1ADD4B1D1F
Q37670065-E062D082-50FD-4A34-A1D2-2D1ADD4B1D1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37670065-E062D082-50FD-4A34-A1D2-2D1ADD4B1D1F
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.
P2860
Q37670065-E062D082-50FD-4A34-A1D2-2D1ADD4B1D1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37670065-E062D082-50FD-4A34-A1D2-2D1ADD4B1D1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0632f6971508249a15f07f77e41cc65c603b927c
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).